122 related articles for article (PubMed ID: 7796835)
1. Motor neuron disease and monoclonal gammopathy.
Lavrnić D; Vidaković A; Miletić V; Trikić R; Marinković Z; Rakocević V; Nikolić J; Wirguin I; Sadiq SA; Apostolski S
Eur Neurol; 1995; 35(2):104-7. PubMed ID: 7796835
[TBL] [Abstract][Full Text] [Related]
2. [Paraproteinemia and motor neuron disease].
Saito T; Irie S; Ito H; Kowa H
Rinsho Shinkeigaku; 1992 Oct; 32(10):1146-8. PubMed ID: 1297563
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance.
Kelly JJ
Rev Neurol Dis; 2008; 5(1):14-22. PubMed ID: 18418318
[TBL] [Abstract][Full Text] [Related]
4. Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study.
Vlam L; Piepers S; Sutedja NA; Jacobs BC; Tio-Gillen AP; Stam M; Franssen H; Veldink JH; Cats EA; Notermans NC; Bloem AC; Wadman RI; van der Pol WL; van den Berg LH
J Neurol; 2015 Mar; 262(3):666-73. PubMed ID: 25549972
[TBL] [Abstract][Full Text] [Related]
5. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
[TBL] [Abstract][Full Text] [Related]
6. [Peripheral neuropathy with monoclonal gammopathy].
Meier T; Meyer M
Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes.
Younger DS; Rowland LP; Latov N; Sherman W; Pesce M; Lange DJ; Trojaborg W; Miller JR; Lovelace RE; Hays AP
Neurology; 1990 Apr; 40(4):595-9. PubMed ID: 2320231
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy and neuropathy.
Ramchandren S; Lewis RA
Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
[TBL] [Abstract][Full Text] [Related]
9. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
Mehndiratta MM; Sen K; Tatke M; Bajaj BK
J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
[TBL] [Abstract][Full Text] [Related]
10. Neuropathies associated with IgG and IgA monoclonal gammopathy.
Nobile-Orazio E; Casellato C; Di Troia A
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):979-87. PubMed ID: 12407307
[TBL] [Abstract][Full Text] [Related]
11. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
13. Fracture risk in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Jensen P; Gislum M; Jørgensen B; Sørensen HT; Nørgaard M
Br J Haematol; 2006 Oct; 135(1):62-7. PubMed ID: 16925792
[TBL] [Abstract][Full Text] [Related]
14. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT
Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of monoclonal gammopathy of undetermined significance in patients with nonimmune chronic idiopathic neutropenia syndrome.
Papadaki HA; Eliopoulos DG; Ponticoglou C; Eliopoulos GD
Int J Hematol; 2001 Apr; 73(3):339-45. PubMed ID: 11345200
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
[TBL] [Abstract][Full Text] [Related]
17. [Pitfalls of monoclonal gammopathy].
Meuleman N
Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
[TBL] [Abstract][Full Text] [Related]
18. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance.
Dizdar O; Erman M; Cankurtaran M; Halil M; Ulger Z; Yavuz BB; Ariogul S; Pinar A; Harputluoglu H; Kars A; Celik I
Ann Hematol; 2008 Jan; 87(1):57-60. PubMed ID: 17874101
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
20. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
